Pfizer Markets for Sale La Jolla, Calif., Incubator Building, With Three Tenant Companies Inside

Pfizer has put its La Jolla, Calif., incubator building up for sale, in one of several moves to restructure its real estate portfolio and cut costs in light of its planned $68 billion acquisition of Wyeth, the San Diego Business Journal reported.

The 26,600-square-foot building, known as CB-7, is listed without an asking price, and has been up for sale since late last year, Cushman & Wakefield broker Steve Rosetta told the Business Journal.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Reuters reports that UK researchers are using gene-editing tools to develop flu-resistant chickens.

Nature calls for genomics to become part of the World Health Organization's cholera surveillance approach.

Vox explores a proposal to institute a lottery system to award grant funds.

In Genome Biology this week: gut microbiome study of individuals from Tanzania and Botswana, sixth version of the Network of Cancer Genes database, and more.